Oracle Life Sciences Wins Best Clinical Trials Supplier Award: Data Management & Analytics at Asia-Pacific Biopharma Excellence Awards 2024


Singapore, (15 April 2024)  – Oracle Life Sciences proudly announced its receipt of the esteemed IMAPAC Best Clinical Trials Supplier Award: Data Management & Analytics. This recognition was presented at the Asia-Pacific Biopharma Excellence Awards 2024, organized by IMAPAC Biopharma Awards. 

Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities.

As an early pioneer in eClinical technologies, over the past decades Oracle has come to understand the technology needs from the simplest trials to the most complex, across many therapeutic areas. This wide-ranging industry knowledge is what has driven the development of holistic clinical trial management platforms such as Oracle Argus and Clinical One. Oracle has the depth and breadth of technology, data, and expertise that enables it to deliver solutions that span the therapeutic development lifecycle, from inception to clinical trials to post-market. 

Yashi Kant, vice president of Oracle Life Sciences Asia Pacific said, “Our alignment with Oracle Health is a force-multiplier of innovation for our customers, with a focus on AI, automation, safety, and advancing clinical trial conduct. For example, we can help bring clinical research into everyday patient care, which provides a continuously learning ecosystem to benefit researchers, patients, and physicians. Oracle Health Data Intelligence will offer our customers an open, connected, and research-ready data ecosystem to unify data, unlock insights, and advance scientific knowledge with speed, agility and security.” 

Oracle Life Sciences is set to continue its collaboration with biopharma customers to develop solutions that can expand patient participation, improve patient experience, and provide a more seamless data flow to aid therapeutic development.

“We are honored to receive this award recognition. It’s a great validation of Oracle’s ongoing commitment to deliver innovative solutions that leverage data to deliver insights that can help pharmaceutical companies deliver new treatments at record speeds,” Kant remarked.


IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.


More Posts

Send Us A Message